Blog Posts

A Program in Wonders and the Technology of Miracles

Posted by stephen005 on September 19, 2024 at 4:16am 0 Comments

At its primary, A Course in Wonders is just a channeled function, and their beginnings are shrouded in mystery. Helen Schucman, a scientific psychologist, and Bill Thetford, a research psychiatrist, worked in the 1960s to transcribe the internal dictations that Schucman stated to receive from an inner style she identified as Jesus Christ. The process of obtaining and taking these messages spanned seven years and led to the three-volume book known as A Program in Miracles.



The Text is… Continue

GCC 2G Disposables: A Comprehensive Guide to Next-Gen Vaping

Posted by se on September 19, 2024 at 4:15am 0 Comments

In recent years, disposable vaping devices have revolutionized the vaping industry, offering a convenient, portable, and hassle-free experience for both novice and experienced users. Among the popular options in the market, GCC 2G Disposables stand out for their cutting-edge technology, sleek design, and superior performance. In this article, we explore the features, advantages, and reasons why GCC 2G Disposables are becoming a top choice for vape enthusiasts.



1. What Are GCC 2G… Continue

Betting Online in Singapore: A Comprehensive Guide to Legal and Safe Practices

Posted by 8nplay on September 19, 2024 at 4:11am 0 Comments

Online betting has become a global phenomenon, offering convenience and excitement to millions of users. In Singapore, online betting is subject to strict regulations, making it essential for users to understand the legal framework and find secure, reputable platforms for betting. This article explores the legal aspects of online betting in Singapore, tips for safe betting, and a look at some of the popular forms of online gambling.…

Continue

Lucky88 đưa tin: Aston Villa khởi đầu ấn tượng ở Champions League 2024/25

Posted by Lucky88 on September 19, 2024 at 4:10am 0 Comments

CLB Aston Villa bắt đầu cuộc phiêu lưu ở Champions League 2024/25 bằng chiến thắng 3-0 hoành tráng trên sân Young Boys. Trong khi đó, nhà cựu vô địch Juventus cũng đã đánh bại PSV với cách biệt 3-1 tại thánh địa Allianz.

Aston Villa khởi đầu như mơ với thắng lợi trước Young Boys

Aston Villa khởi đầu như mơ với thắng lợi trước Young Boys



Xem thêm:… Continue

the cell therapy manufacturing market is estimated to reach close to USD 11 Billion - "Roots Analysis"

The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity

Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030” report to its list of offerings.

Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years. Therefore, both therapy developers and contract service providers may need to strengthen their capabilities and expand available capacity. In this context, automation is expected to be a key enabler within the cell therapy manufacturing and contract services industry.

To order this 550+ page report, which features 160+ figures and 250+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/cell-therapy-ma...

Key Market Insights

More than 160 organizations claim to be engaged in cell therapy manufacturing
The market landscape is dominated by industry players, representing more than 60% of the total number of stakeholders. Amongst these, over 55 are large or mid-sized firms (having more than 50 employees).

100+ players focused on T-cell and stem cell therapies
Most of these players are focused on manufacturing T-cell therapies, including CART, TCR or TILs. It is worth highlighting that more than 35 organizations claim to have necessary capabilities for the manufacturing of both types of therapies.

Presently, 70+ companies have commercial scale capacity
As majority of the cell therapy products are in clinical trials, the demand is high at this scale. However, it is worth noting that several players (~50%) have already developed commercial scale capacity for cell therapies.

Europe is currently considered a current hub for cell therapy production
More than 220 manufacturing facilities have been established by various players, worldwide; of these, 35% are in Europe, followed by those based in North America. Other emerging regions include Australia, China, Japan, Singapore, South Korea and Israel.

50+ facility expansions reported between 2015-2019
More than 85% of the expansions are related to setting up of new facilities across different regions. Maximum expansion activity was observed in the US and in certain countries within the Asia Pacific regions.
20+ companies offer automated solutions to cell therapy developers
Players that claim to offer consultancy services related to automation include (in alphabetical order) Berkeley Lights, Cesca Therapeutics, Ferrologix, FluDesign Sonics, GE Healthcare and Terumo BCT. Further, we identified players, namely (in alphabetical order) Fraunhofer Institute for Manufacturing Engineering and Automation IPA, Invetech, KMC Systems, Mayo Clinic Center for Regenerative Medicine and RoosterBio, that offer consultancy solutions related to automation.

Partnership activity has grown at an annualized rate of 16%, between 2014 and 2018
More than 200 agreements have been inked in the last 5 years; majority of these were focused on the supply of cell-based therapy products for clinical trials. Other popular types of collaboration models include manufacturing process development agreements (16%), services agreements (12%) and acquisitions (10%).

By 2030, developed geographies will capture over 60% of the market share
Asia Pacific is anticipated to capture the major share (~36%) of the market by 2030. It is also important to highlight that financial resources, technical expertise and established infrastructure is likely to drive cell therapy manufacturing market in Europe, which is estimated to grow at a CAGR of ~26%.

Contact:
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]

Views: 2

Comment

You need to be a member of On Feet Nation to add comments!

Join On Feet Nation

© 2024   Created by PH the vintage.   Powered by

Badges  |  Report an Issue  |  Terms of Service